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ABSTRACT 
Sarcopenia is an important factor in the occurrence of complications in 
elderly patients with urgent surgical pathology. Decreased muscle strength 
and function is an important criterion for impaired early activation of such 
patients, which increases the number of complications and length of stay in 
the clinic. Identification of functional disorders of muscle tissue, as well as 
other metabolic disorders, such as type 2 diabetes, disorders of lipid 
metabolism, is important for the appointment of an adequate complex of 
intensive care. Prescribing levocarnitine and D-fructose-1,6-diphosphate 




metabolic disorders,  
levocarnitine,  
intensive therapy. 
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Introduction. According to the European Working Group on Sarcopenia in Older People 
(EWGSOP), "Sarcopenia is a syndrome characterized by progressive and generalized loss of muscle 
mass and muscle strength with an increased risk of adverse events such as impaired mobility, impaired 
quality of life, or death." [1]. According to the US Center for Disease Control and Prevention (CDC), 
sarcopenia is considered one of the top five risk factors for morbidity and mortality in people over 65; 
associated with an increased risk of all-cause mortality and decreased self-care ability [2].  
Sarcopenia is classified as primary or age-related when aging is the main cause of its 
development and other causes of this condition are excluded [3]. Sarcopenia, which develops against 
the background of severe eating disorders or restrictions on mobility, as well as against the 
background of other diseases, is secondary [4]. Sarcopenia is a polyetiologic disease, and therefore, in 
some patients it is difficult and impossible to isolate primary or secondary sarcopenia. 
Multiple factors are associated with decreased muscle mass and / or strength in older adults [5, 
6]. The underlying causes or mechanisms associated with sarcopenia include inadequate nutrition, lack 
of exercise, bed rest, age-related hormonal changes, loss of motor neurons, atherosclerosis, obesity, 
insulin resistance, and exposure to inflammatory cytokines. 
With age, the distribution of fat mass in the body changes, there is an increase in abdominal 
fat and a decrease in subcutaneous fat mass [7, 8]. Simultaneously, there is a decrease in the quality of 
muscles, namely, a decrease in the size and number of muscle fibers (loss of type II fibers prevails), a 
decrease in muscle protein synthesis and a decrease in mitochondrial function [9, 10]. In patients with 
an excessive amount of fat mass, a change in lipid metabolism in muscles was noted. Increased 
infiltration of muscle tissue with lipids and adipose tissue both inside and around muscle cells. This is 
likely due to a systemic increase in free fatty acids [11]. According to the literature, the results of 
computed tomography demonstrate, when scanning at the level of the middle third of the thigh, an 
increase in the amount of fat mass in and around the muscles [12]. Thus, aging includes an increase 
and redistribution of fat mass, and changes in muscle mass: "more fat, less muscle." 
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The aim of the study was to determine the severity of sarcopenia in elderly patients with 
urgent surgical pathology of the abdominal cavity. 
Materials and methods  
The study was a clinical prospective open cohort randomized and was conducted on the basis 
of the Department of Anesthesiology and Intensive Care for patients of the surgical profile of the 
municipal non-profit enterprise "City Clinical Hospital of Ambulance and Emergency Care. prof. OI 
Meshchaninov" Kharkiv City Council and on the basis of the Department of Intensive Care of the 
State Institution" Institute of General Emergency Surgery named after V.T. Zaitseva" of the National 
Academy of Medical Sciences of Ukraine (2019–2020). To achieve this goal, we examined 90 elderly 
patients (73.3 ± 7.9 years) with surgical pathology of the abdominal cavity, who underwent emergency 
surgery under general anesthesia based on sodium thiopental with artificial lung ventilation, the 
average duration of which was 109,2 ± 24,6 min. The inclusion criteria were: age at least 60 years; 
absence of somatic diseases in the stage of decompensation, class II-III according to the ASA 
classification. Depending on the protocol of postoperative therapy, patients were divided into 3 
groups, and they were domesticated by age, sex, anthropometric data, volume and duration of surgery 
and concomitant comorbid background (table 1). 
 




І ІІ ІІІ 
Number of patients 30 30 30 
Men 9 10 8 
Women 21 20 22 
Age, years 72,4±6,1 72,1±5,6 72,2±5,9 
Height, sm 161,2±10,4 164,4±12,1 162,6±11,9 
Body weight, kg 76,8±7,9 78,4±6,7 78,1±6,9 
Duration of operation, min. 109,4±31,1 110,1±29,6 109,8±32,2 
 
Group I (n = 30) - patients who underwent standard intensive perioperative therapy, group II 
(n = 30): standard intensive therapy with the addition of levocarnitine from the first day of stay in the 
intensive care unit 15 mg / kg body weight per day intravenously slowly; group III (n = 30): standard 
intensive care with the addition of levocarnitine from the first day of stay in the intensive care unit 
15 mg / kg body weight per day intravenously slowly for 5 days and a solution of D-fructose-1,6-
diphosphate sodium salt of hydrate 150 mg / kg 2 times daily intravenously at a rate of 10 ml per 
minute for 5 days in the clinic. 
By type a concomitant somatic pathology, patients were distributed as follows: hypertension 
1-2 tbsp. I group of 12 patients, II group of 14 patients, III group of 12 patients; coronary heart disease 
Group I 17 patients, Group II 15 patients, Group III 14 patients; heart failure I-IIA class I group 22 
patients, II group 20 patients, III group 18 patients; type II diabetes mellitus group I 28 patients, group 
II 27 patients, group III 27 patients. All patients with confirmed type II diabetes mellitus at the time of 
admission received metformin 1827.2 ± 236.1 mg per day as antidiabetic therapy. 
During the interview, the patient clarified the presence of complaints of impaired mobility, 
difficulty walking, getting up from a chair. Anamnestic data on the presence of falls and fractures in 
the anamnesis were evaluated. At the time of admission, data on glycated hemoglobin levels and other 
laboratory parameters (glucose, creatinine, total protein and albumin, serum lipid parameters, protein 
in single and / or daily urine) were copied from outpatient charts, statements, medical histories. 
The diagnosis of sarcopenia was based on the recommendations proposed by the European 
Working Group on Sarcopeniain Older People (EWGSOP, 2009) [1]. 
The diagnosis was based on the determination of muscle mass, strength and function. When 
diagnosing sarcopenia, the EWGSOP recommends the following criteria: Decreased muscle mass 
combined with decreased muscle strength or muscle function. 
There were 3 stages of sarcopenia, according to EWGSOP recommendations: presarcopenia, 
sarcopenia, severe sarcopenia [1]. In patients with a decrease in muscle mass index alone, the stage of 
presarcopenia was established; with a decrease in muscle mass and muscle strength, the stage of 
sarcopenia was established. 
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The study of muscle mass was performed immediately after surgery in the operating room 
using the method of bioimpedancemetry on the analyzer "MEDASS" ABC-02. After obtaining the 
results of the measurement of skeletal muscle mass in kg, the calculation of the musculoskeletal mass 
index (SMM (kg) / height (m2) = ISMM, kg / m2) was performed. The ISMM corresponding to the 
decrease in muscle mass was taken to be less than 6.75 kg / m2. 
Evaluation of muscle strength was performed by the method of wrist dynamometry using a 
mechanical wrist dynamometer DK-25, the evaluation of this indicator was performed taking into 
account the body mass index. 
To be able to use the Student's t test, the Fischer-Snedekor test was calculated - the ratio of the 
larger variance to the smaller one. All mathematical operations and graphical constructions were 
performed using the software packages "Microsoft Office XP": "Microsoft XP Home" and "Microsoft 
Excel XP". 
Results of the research  
It was important to determine the peculiarities of metabolism and muscle condition in patients 
at the time of their occurrence of urgent surgical pathology. Since, according to many authoritative 
sources [13, 14], more than 80% of elderly patients treated in surgical clinics have a reduced 
sarcopenic index, regardless of body mass index, it was important to compare the length of stay of 
patients in groups I, II and III in the intensive care unit and in the clinic in general, taking into account 
the additional appointment in patients of groups II and III of substances that in one way or another 
affect the functional state of the muscles. 
On the first day of stay in the clinic we will identify the following features of the metabolism 
of the studied patients (table 2). 
Table 2. Clinical characteristics of the studied patients 
Indicators 
Groups 
І (n=30) ІІ (n=30) ІІІ (n=30) 
Presarcopenia, % 53% (16) 47% (14) 43% (13) 
Sarcopenia, % 47% (14) 53% (16) 57% (17) 
BMI, (kg / m2) 26,2±0,4 25,9±0,2 26,4±0,6 
HbA1c (%) 8,4±0,2 7,9±0,4 8,1±0,4 
Dynamometry 
(right hand, best 
result from 2 attempts), kg 
16,2±1,2 15,9±1,6 16,4±1,7 
Reduced muscle strength according to 
KDM data, (%) 
67,2±3,1 65,8±5,2 66,1±4,9 
Intake of statins, % 93% 90% 96% 
Creatinine, μmol / L 82,4±6,2  81,8±4,6 82,2±5,1 
GFR, ml / min / 1,73m2 60,2±8,2 62,6±7,1 61,9±6,4 
Total cholesterol, mmol / l 5,08±0,4 4,48±0,6 5,11±0,2 
Total protein, g / l 72,4±2,7 71,9±4,4 70,2±2,6 
The number of treatment days in ICU 5,4±1,1 4,1±0,4 3,2±0,2*І,ІІІ*ІІ,ІІІ 
* - р˂0,05 - probable difference between groups 
 
At the initial analysis to determine the metabolic status of elderly patients treated in the 
surgical department for emergency surgery was 53%, 47% and 43% in patients of groups I, II and III, 
respectively, or sarcopenia, 47%, 53% and 57% in patients of groups I, II and III, respectively. Also 
important was the presence of elevated glycated hemoglobin (HbA1c), which was 8.4 ± 0.2%, 
7.9 ± 0.4% and 8.1 ± 0.4% in patients of groups I, II and III, respectively, which indicated the 
presence of type II diabetes mellitus, which characterizes the corresponding changes in the body by 
carbohydrate metabolism. Despite the almost normal body mass index in most patients, BMI 
26.2 ± 0.4 kg / m2, 25.9 ± 0.2 kg / m2 and 26.4 ± 0.6 kg / m2 in groups I, II and III, respectively, it 
was important to determine the dynamics and muscle strength, which confirmed the presence of 
presarcopenia / sarcopenia in all patients. Thus, in group I the indicators of dynamometry and muscle 
strength were 16.2 ± 1.2 kg and 67.2 ± 3.1%, in group II - 15.9 ± 1.6 kg and 65.8 ± 5.2 %, in group III 
- 16.4 ± 1.7 kg and 66.1 ± 4.9%, respectively. 
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It was important to obtain data on the use of statins in the studied patients. Thus, more than 90% of 
elderly patients admitted to a surgical hospital with urgent pathology had disorders of lipid metabolism. 
The block status of patients was satisfactory, which indicated the acute origin of surgical pathology. 
Given the fact that the fundamental difference between the groups, taking into account the 
pathogenetic mechanisms of sarcopenia, was the appointment of a solution of levocarnitine in group II 
and a solution of levocarnitine in parallel with a solution of D-fructose-1,6-diphosphate sodium salt of 
hydrate in group III, probable ( p˂0.05) differences in the number of days of treatment of patients in 
the intensive care unit, 5.4 ± 1.1 days in group I, 4.1 ± 0.4 days in group II, 3.2 ± 0.2 days in patients 
of group III indicated the importance of the functional state of the muscles during the postoperative 
period in elderly patients with urgent surgical pathology. 
Conclusions. 
Sarcopenia in elderly patients admitted to a surgical hospital is an important factor influencing 
the duration of treatment in the intensive care unit and, consequently, the occurrence of complications. 
The appointment of levocarnitine is pathogenetically justified in this group of patients as a 
protector of the functional state of muscle tissue. 
The appointment of D-fructose-1,6-diphosphate sodium salt of hydrate is an important 
component of the algorithm of intensive care in elderly patients with surgical pathology, which has an 
energy-protective effect and promotes their early activation. 
Conflict of interest. The authors do not declare a conflict of interest. 
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